<ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>
    歡迎來到上海通蔚!

    021-54845833/15800441009

    品質(zhì)保證 · 通蔚試劑

    當前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗ABL1ABL2(phospho-Tyr393439)多克隆抗體

    產(chǎn)品中心

    最新產(chǎn)品

    • 兔抗ABL1ABL2(phospho-Tyr393439)多克隆抗體

      規(guī)格:
      價格:
      • 品牌 : 通蔚生物
      • 目錄號 : TW680
      • 應用 : 僅用于科研使用
      • 貨期 : 現(xiàn)貨
      • 規(guī)格 :100ul/200ul/25ul
    • 商品詳情
    • 參考文獻
    • 說明書下載
    • 商品評論0
    • 相關(guān)產(chǎn)品

    中文名稱: 兔抗ABL1/ABL2 (phospho-Tyr393/439)多克隆抗體


    英文名稱:
    Anti-ABL1/ABL2 (phospho-Tyr393/439) rabbit polyclonal antibody

    別      名: Abelson murine leukemia viral oncogene homolog 1; c-ABL; p150

    相關(guān)類別: 一抗

    儲      存: 冷凍(-20℃) 避光

    宿      主: Rabbit

    抗      原:
    ABL1/ABL2(phospho-Tyr393/439)

    反應種屬: Human, Mouse

    標 記 物: Unconjugate

    克隆類型: rabbit polyclonal

    技術(shù)規(guī)格

    Background:

    Regulates cytoskeleton remodeling during cell differentiation, cell division and cell adhesion. Localizes to dynamic actin structures, and phosphorylates CRK and CRKL, DOK1, and other proteins controlling cytoskeleton dynamics. Regulates DNA repair potentially by activating the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks.

    Applications:

    WB, IHC, IF

    Name of antibody:

    ABL1/ABL2(phospho-Tyr393/439)

    Immunogen:

    Peptide sequence around phosphorylation site of tyrosine 393/439 (D-T-Y(p)-T-A) derived from Human ABL1/2.

    Full name:

    ABL proto-oncogene 1, non-receptor tyrosine kinase/ABL proto-oncogene 2, non-receptor tyrosine kinase

    Synonyms:

    ABL; JTK7; p150; c-ABL; v-abl; CHDSKM; c-ABL1; bcr/abl; ARG; ABLL

    SwissProt:

    P00519/P42684

    IHC positive control:

    Human breast carcinoma

    IHC Recommend dilution:

    50-100

    WB Predicted band size:

    210 kDa

    WB Positive control:

    HL60 cells

    WB Recommended dilution:

    500-1000

    IF Positive control:

    Hela cells

    IF Recommended dilution:

    100-200




    產(chǎn)品掃碼查看詳情
    手機掃描查看
    <ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>